/ /

  • linkedin
  • Increase Font
  • Sharebar

    Quiz: 2017 ACC/AHA/HFSA Update to 2013 HF Guidelines


    The correct answer is: B. <130/80 mmHg

    In the 2017 focused update, the ACC/AHA/HFSA newly recommended that the optimal blood pressure for the prevention of HF in patients at increased CV risk (age >75 years, established vascular disease, chronic renal disease, or a Framingham Risk Score >15%), should be 130/80 mm Hg. Targeting systolic blood pressure in patients with increased CV risk represents a new strategy for the prevention of HF. It is based on new RCT data suggesting that controlling systolic blood pressure to <120 mmHg was linked to significantly decreased HF and decreased CV death overall.2 Because blood pressure measured in a clinical setting is usually 5 to 10 mmHg higher compared to a research setting, the recommendation is to target blood pressure to <130/80 mmHg in clinical practice.1


    3. Which of the following patients should not receive an angiotensin receptor neprilysin inhibitor (ARNI)?

    A. A patient who is already on an ACE-I

    B. A patient with a history of angioedema

    C. A patient with HFrEF NYHA class II that remains symptomatic despite treatment with enalapril

    D. Neither A or B


    Please click here for answer and discussion.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available